Literature DB >> 11559870

Latent trait standardization of the benzodiazepine dependence self-report questionnaire using the Rasch scaling model.

C C Kan1, A H van der Ven, M H Breteler, F G Zitman.   

Abstract

The aim of the present study was to obtain standardized scores that correspond with the raw scores on the four Rasch scales of the Benzodiazepine Dependence-Self Report Questionnaire (Bendep-SRQ). The eligible normative group for standardization of the Bendep-SRQ scales consisted of 217 general practice (GP) patients, all using benzodiazepines. Two standardization methods were used and compared: "classical standardization," which transforms raw scores into standard scores on the unit normal distribution, and "latent trait standardization," which transforms raw scores into latent trait scores. The latter requires the Rasch model with the additional assumption of a normally distributed latent trait, which held true for the scales "problematic use," "lack of compliance," and "withdrawal," but not for "preoccupation." The observed unequal item spacing on the "preoccupation" scale was hypothesized to induce a response tendency of nondeviation, causing a local violation of the assumption of a normally distributed latent trait. Nevertheless, comparison of the results of the two standardization methods revealed such a high degree of resemblance, that latent trait standardization could be used for "preoccupation" just as well as classical standardization. The presented standard scores and corresponding percentile ranks make raw Bendep-SRQ scores clinically interpretable in relation to the normative GP sample. Incorporation of the Rasch scaling methodology into the development of the Bendep-SRQ marks the adoption of the item response theory in the field of applied test methodology. In this process, it appears that equal item spacing has to be taken into account to prevent local violations of the Rasch model with the additional assumption of a normally distributed latent trait. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559870     DOI: 10.1053/comp.2001.26276

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  4 in total

1.  Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures.

Authors:  Harold S Javitz; Janet Brigham; Christina N Lessov-Schlaggar; Ruth E Krasnow; Gary E Swan
Journal:  Addiction       Date:  2009-06       Impact factor: 6.526

2.  Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.

Authors:  Mai Yamamoto; Ken Inada; Minori Enomoto; Mitsunari Habukawa; Takahisa Hirose; Yuichi Inoue; Jun Ishigooka; Yuichi Kamei; Tsuyoshi Kitajima; Masayuki Miyamoto; Hideto Shinno; Katsuji Nishimura; Motohiro Ozone; Masahiro Takeshima; Mayumi Suzuki; Hidehisa Yamashita; Kazuo Mishima
Journal:  Neuropsychopharmacol Rep       Date:  2020-12-01

3.  A Qualitative Study of Use of Mindfulness to Reduce Long-Term Use of Habit-Forming Prescription Drugs.

Authors:  Ingrid Dundas; Kari Ravnanger; Per-Einar Binder; Signe Hjelen Stige
Journal:  Front Psychiatry       Date:  2020-11-12       Impact factor: 4.157

4.  Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study.

Authors:  Yuichi Inoue; Yoshikazu Takaesu; Michinori Koebis
Journal:  BMC Psychiatry       Date:  2021-04-14       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.